Raul Gainetdinov
Born
Raul R. Gainetdinov

(1964-09-01) September 1, 1964
Known forTAAR
Dopamine receptors
Scientific career
FieldsNeuropsychopharmacology
Medicine
Biology
InstitutionsDuke University
Italian Institute of Technology
Saint Petersburg University
Academic advisors

Raul Gainetdinov (born September 1, 1964) is a pharmacologist and neuroscientist. The main direction of his research is psychiatric and neurological diseases of the brain, such as schizophrenia, ADHD, depression and Parkinson's disease. He is the author of fundamental scientific works in pharmacology of dopamine,[1] β-Arrestins[2][3] and NMDA receptors.[4] He is a pioneer researcher of Trace amine-associated receptors.[5][6][7]

Education

He earned an MD degree from the Second Moscow Medical Institute (now the Russian National Research Medical University) in 1988, followed by a PhD degree in Pharmacology in 1992 from the Russian Academy of Medical Sciences.[8]

Career

Influence

Since 2018 Raul Gainetdinov has been included in the Web of Science Highly Cited Researchers list.[13][14] h-index 82.[15]

Since 2013 he has been the chairman of the nomenclature committee for dopamine receptors of International Union of Basic and Clinical Pharmacology (IUPHAR).[16]

Pictures

Gainetdinov Lefkowitz Caron
Back row: Raul Gainetdinov, Marc Caron,[17] Robert Lefkowitz
Front row: Laura Bohn,[18] Fang Lin[19]

References

  1. ↑ Beaulieu JM, Gainetdinov RR (2011-03-01). "The Physiology, Signaling, and Pharmacology of Dopamine Receptors". Pharmacological Reviews. 63 (1): 182–217. doi:10.1124/pr.110.002642. PMID 21303898. S2CID 2545878.
  2. ↑ Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005-07-29). "An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior". Cell. 122 (2): 261–273. doi:10.1016/j.cell.2005.05.012. PMID 16051150.
  3. ↑ Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999-12-24). "Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2". Science. 286 (5449): 2495–2498. doi:10.1126/science.286.5449.2495. PMID 10617462.
  4. ↑ Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999-08-20). "Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia". Cell. 98 (4): 427–436. doi:10.1016/S0092-8674(00)81972-8. PMID 10481908.
  5. ↑ Premont RT, Gainetdinov RR, Caron MG (2001-08-14). "Following the trace of elusive amines". Proceedings of the National Academy of Sciences. 98 (17): 9474–9475. Bibcode:2001PNAS...98.9474P. doi:10.1073/pnas.181356198. PMC 55475. PMID 11504935.
  6. ↑ Sotnikova TD, Caron MG, Gainetdinov RR (2009-04-23). "Trace Amine-Associated Receptors as Emerging Therapeutic Targets". Molecular Pharmacology. 76 (2): 229–235. doi:10.1124/mol.109.055970. PMC 2713119. PMID 19389919.
  7. ↑ Gainetdinov RR, Hoener MC, Berry MD (2018-07-01). "Trace Amines and Their Receptors". Pharmacological Reviews. 70 (3): 549–620. doi:10.1124/pr.117.015305. PMID 29941461.
  8. ↑ "Raul R. Gainetdinov, MD, PhD | Parkinson's Disease". www.michaeljfox.org. Retrieved 2022-08-09.
  9. ↑ "Dr. Raul R Gainetdinov | Insight Medical Publishing". www.imedpub.com. Retrieved 2021-09-20.
  10. 1 2 3 "Institute of Translational Biomedicine".
  11. ↑ "Raul Gainetdinov". ORCID. Retrieved 2022-08-12.
  12. ↑ "Laboratory of Neuroscience and Molecular Pharmacology".
  13. ↑ "Web of Science Highly Cited Researchers 2019". Web of Science.
  14. ↑ "Web of Science Highly Cited Researchers 2020". Web of Science.
  15. ↑ "Raul R. Gainetdinov".
  16. ↑ "IUPHAR subcommittee and family contributors".
  17. ↑ "Marc G. Caron".
  18. ↑ "Laura Bohn".
  19. ↑ "Fang-Tsyr Lin".

PubMed search for Raul R. Gainetdinov

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.